Loading company…
Oligogen develops regenerative medicine therapies for neurological disorders.
Founded in 2015 in Kyoto, Japan, Oligogen develops cell and exosome therapies for neurological disorders, including treatments based on its Oligogeny neural stem cell technology. In August 2017, it raised JPY 111 million in Series A funding from Kyoto University Innovation Capital, Nissay Capital, PF Capital, and SMBC Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in